Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Colorectal Cancer
- Bladder Cancer
- Chemoprevention
- Chemotherapy and Radiotherapy
- Thoracic Oncology
- Immunotherapy
- Pancreatic Cancer
- Cervical Cancer
Abstract
Citation: Clin Oncol. 2021;6(1):1858.DOI: 10.25107/2474-1663.1858
Isolated Kidney Metastases from Rectal Cancer: Report of an Unusual Pattern of Recurrence
Gerardo Rosati, Francesco Conte, Patrizia Siciliano, Marianna Giampaglia, Domenico Bilancia, and Enrico Scarano
Medical Oncology Unit, San Carlo Hospital, Potenza, Italy
Department of Radiology, San Carlo Hospital, Potenza, Italy
Department of Histopathology, San Carlo Hospital, Potenza, Italy
*Correspondance to: Gerardo Rosati
PDF Full Text Case Report | Open Access
Abstract:
Kidney metastases from Rectal Cancer (RC) are quite rare. Only one case has, to the best of our knowledge, been reported. We present the case of a 56-year-old man with lung metastases from a rectal adenocarcinoma diagnosed in October 2015. In June 2018, he developed microhematuria during treatment with regorafenib administered as second-line therapy. The computed tomography scans of the whole body revealed lung disease progression and a solid mass in the cortical site of the left lower kidney. A biopsy was performed and the pathologic examination showed moderately differentiated adenocarcinoma consistent with RC. The tumoral cells stained positively for cytokeratine 20 and CDX2. The administration of third-line chemotherapy plus aflibercept resulted in a dimension reduction of metastases and disappearance of microhematuria. Here we describe the advantages of diagnosing this unusual pattern of metastasization from RC and how it can be explained.
Keywords:
Arterial dissemination; Chemotherapy; Kidney metastases; Rectal cancer; Regorafenib
Cite the Article:
Rosati G, Conte F, Siciliano P, Giampaglia M, Bilancia D, Scarano E. Isolated Kidney Metastases from Rectal Cancer: Report of an Unusual Pattern of Recurrence. Clin Oncol. 2021;6:1858..